Soumya Swaminathan | |
---|---|
Born | |
Alma mater | |
Occupations |
|
Title | Chief Scientist, World Health Organization |
Spouse | Ajit Yadav |
Children | 2 |
Parents |
|
Deputy Director of the World Health Organization | |
In office 2017 –March 2019 | |
Soumya Swaminathan (born 2 May 1959) is an Indian paediatrician and clinical scientist known for her research on tuberculosis and HIV. [1] From 2019 to 2022, she served as the chief scientist at the World Health Organization under the leadership of Director General Tedros Adhanom Ghebreyesus. [2] Previously, from October 2017 to March 2019, she was the Deputy Director General of Programmes (DDP) at the World Health Organization. [3] [4]
Soumya Swaminathan was born in Chennai, [5] India. Swaminathan is the daughter of "Father of Green Revolution of India", M. S. Swaminathan and Indian educationalist Mina Swaminathan. [6] Swaminathan has two siblings, Madhura Swaminathan, a professor of economics at the Indian Statistical Institute, Bangalore, [7] and Nitya Rao, a professor of gender and development at the University of East Anglia. [8]
Swaminathan received an M.B.B.S. from the Armed Forces Medical College in Pune. She has an M.D. in pediatrics from All India Institute of Medical Sciences in New Delhi. She is a Diplomate of National Board from National Board of Examinations. As part of her training, from 1987 to 1989 Swaminathan completed a post-doctoral medical fellowship in neonatology and pediatric pulmonology at the Children's Hospital Los Angeles at the Keck School of Medicine of USC. [9]
From 1989 to 1990, Swaminathan was a research fellow (registrar) in the Department of Pediatric Respiratory Diseases at the University of Leicester in the United Kingdom. [10]
She then worked as a senior research officer (Supernumerary Research Cadre), Cardiopulmonary Medicine Unit, as well as an adjunct associate clinical professor at the Department of Public Health and Family Medicine at Tufts University School of Medicine in Massachusetts. [11]
In 1992, Swaminathan joined the National Institute for Research in Tuberculosis a/k/a Tuberculosis Research Centre, where she was Coordinator, Neglected Tropical Diseases. She later became the director of the National Institute for Research in Tuberculosis. [9]
From 2009 to 2011, Swaminathan was coordinator of the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases in Geneva.
Until 2013, she was director, National Institute for Research in Tuberculosis (NIRT) in Chennai.
From August 2015 to November 2017, Swaminathan was director general of the Indian Council of Medical Research (ICMR) and secretary of the Department of Health Research (Ministry of Health & Family Welfare) for the Government of India. [9] [12]
From October 2017 to March 2019, Swaminathan was Deputy Director-General of the World Health Organization. [3] [4]
In March 2019, Swaminathan became chief scientist of the World Health Organization, where she notably participated in regular twice weekly press briefings on the COVID-19 pandemic. [2] She has urged countries to conduct whole genome sequencing of the SARS-CoV-2 virus more frequently and to upload sequences to the GISAID project. [13]
In the preparations for the Global Health Summit hosted by the European Commission and the G20 in May 2021, Swaminathan was a member of the event's High Level Scientific Panel. [14]
Swaminathan's areas of interest are pediatric and adult tuberculosis (TB), epidemiology and pathogenesis, and the role of nutrition in HIV-associated TB. [9] [15]
While at the National Institute for Research in Tuberculosis in Chennai, Swaminathan started a multi-disciplinary group of clinical, laboratory and behavioural scientists studying various aspects of TB and TB/HIV. Swaminathan along with her colleagues were among the first to scale up the use of molecular diagnostics for TB surveillance and care, to undertake large field trials of community-randomised strategies to deliver TB treatment to underserved populations. [16] She was part of the TB Zero City Project which aimed to create "Islands of elimination" working with local governments, institutions and grassroots associations. [17] [18]
In 2021, Swaminathan was also appointed to the Pandemic Preparedness Partnership (PPP), an expert group chaired by Patrick Vallance to advise the G7 presidency held by the government of Prime Minister Boris Johnson. [19]
Swaminathan is married to Ajit Yadav, an orthopedic surgeon. [30] [31] The couple has a daughter, Shreya Yadav and a son, Akshay Yadav.
Sir Peter Karel, Baron Piot, is a Belgian-British microbiologist known for his research into Ebola and AIDS.
The Canadian Institutes of Health Research is a federal agency responsible for funding health and medical research in Canada. Comprising 13 institutes, it is the successor to the Medical Research Council of Canada.
GISAID, the Global Initiative on Sharing All Influenza Data, previously the Global Initiative on Sharing Avian Influenza Data, is a global science initiative established in 2008 to provide access to genomic data of influenza viruses. The database was expanded to include the coronavirus responsible for the COVID-19 pandemic, as well as other pathogens. The database has been described as "the world's largest repository of COVID-19 sequences". GISAID facilitates genomic epidemiology and real-time surveillance to monitor the emergence of new COVID-19 viral strains across the planet.
Margaret Ann "Peggy" Hamburg is an American physician and public health administrator, who is serving as the chair of the board of the American Association for the Advancement of Science (AAAS) and co-chair of the InterAcademy Partnership (IAP). She served as the 21st Commissioner of the U.S. Food and Drug Administration from May 2009 to April 2015.
Sir Jeremy James Farrar is a British medical researcher who has served as Chief Scientist at the World Health Organization since 2023. He was previously the director of The Wellcome Trust from 2013 to 2023 and a professor of tropical medicine at the University of Oxford.
Gagandeep Kang FRS is an Indian microbiologist and virologist who has been leading the work on enteric diseases, diarrheal infections and disease surveillance at the Bill & Melinda Gates Foundation since 2023.
The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).
Francine NtoumiPh.D., HDR, PvDz, FRCPedin is a Congolese parasitologist specializing in malaria. She was the first African person in charge of the secretariat of the Multilateral Initiative on Malaria (2006-2010). In recent years, she has become involved in research on other infectious diseases, including COVID-19.
Linda-Gail Bekker MBChB, DTMH, DCH, FCP(SA) is a Professor of Medicine and Chief Operating Officer of the Desmond Tutu HIV Foundation. She is also Director of the Desmund Tutu HIV Centre at the University of Cape Town. She is a Past President of the International AIDS Society (2016-18).
Anita Kaniz Mehdi Zaidi is a Pakistani physician. She is the President of the Gender Equality Division and Director of Vaccine Development, Global Health Surveillance, Diarrhea and Enteric Diseases at the Bill & Melinda Gates Foundation. She has previously served as Professor of Paediatrics and Child Health at the Aga Khan University.
Richard Hatchett is an American oncologist and epidemiologist who has been serving as chief executive officer of the Coalition for Epidemic Preparedness Innovations (CEPI) in Oslo and London since 2017. He was awarded the Secretary of Health and Human Services's Award for Distinguished Service.
Patricia Jannet García Funegra is a Peruvian professor of public and global health at Cayetano Heredia University. She originally trained as a clinician before focusing on research and public health. Her work also focuses on reproductive health, sexually transmitted diseases, and medical informatics. In 2016-17 García was the Minister of Health of Peru. She was the first Peruvian to be elected to the US National Academy of Medicine in 2016.
The Access to COVID-19 Tools Accelerator, or the Global Collaboration to Accelerate the Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed al-Jadaan on 24 April 2020. A call to action was published simultaneously by the World Health Organization (WHO) on 24 April. As of January 2022, it was the largest international effort to achieve equitable access to COVID-19 health technologies.
John N. Nkengasong is a Cameroonian-American virologist serving as the Global AIDS Coordinator in the Biden administration since 2022 and Senior Bureau Official for Global Health Security and Diplomacy since 2023. He previously worked as the Director of the Africa Centres for Disease Control and Prevention from 2016 to 2022, as well as at the World Health Organization (WHO) and Centers for Disease Control and Prevention. During the COVID-19 pandemic, Nkengasong was appointed the WHO Special Envoy for Africa.
The Women Leaders in Global Health Conference, created by Michele Barry and first held in 2017 at Stanford University in partnership with Women in Global Health, the US National Institutes of Health and others, is an international conference that engages both men and women to address the gender gap in global health leadership.
Poonam Khetrapal Singh is the first Indian elected Regional Director of WHO’s South-East Asia Region. She was also the first woman in the region to assume the office of WHO Regional Director for South-East Asia in February 2014. In September 2018, she was unanimously elected for a second five-year term by the 71st Regional Committee and 144th Session of the WHO Executive Board.
Madhukar Pai is an Indian medical doctor, academic, advocate, writer, and university professor. Pai's work is around global health, specifically advocacy for better treatment for tuberculosis with a focus on South Africa and India. Pai is the inaugural Chair of the Department of Global and Public Health in the School of Population and Global Health and holds a Canada Research Chair in Epidemiology and Global Health at McGill University.
Gary P. Kobinger is a Canadian immunologist and virologist who is currently the director at the Galveston National Laboratory at the University of Texas. He has held previous professorships at Université Laval, the University of Manitoba, and the University of Pennsylvania. Additionally, he was the chief of the Special Pathogens Unit at the National Microbiology Laboratory (NML) of the Public Health Agency of Canada (PHAC) in Winnipeg, Manitoba, for eight years. Kobinger is known for his critical role in the development of both an effective Ebola vaccine and treatment. His work focuses on the development and evaluation of new vaccine platforms and immunological treatments against emerging and re-emerging viruses that are dangerous to human health.
Pragya D. Yadav is an Indian scientist at the ICMR-National Institute of Virology (NIV), who is known for her research contributions in the field of communicable diseases and highly pathogenic viral infections, such as Crimean–Congo hemorrhagic fever (CCHF), Nipah, Ebola, leading to improvising national public health surveillance policy for interventions and management. Yadav is among the scientists who detected the first three COVID-19 pandemic cases in India. She headed the team that developed Covaxin, the first indigenous COVID-19 vaccine in India
Kayla F. Laserson is an American epidemiologist serving as the director of the Global Health Center at the Centers for Disease Control and Prevention (CDC) since July 2023. She was previously the deputy director for Infectious Diseases and Vaccine Delivery, India Office of the Bill & Melinda Gates Foundation. Laserson served as a commander in the United States Public Health Service Commissioned Corps until 2007.
{{cite web}}
: CS1 maint: bot: original URL status unknown (link)